Home > Specialists > Neurosurgery > Dr. Song Lin (林松)
Specialty & Clinical Focus:
Neurosurgery specialist at Beijing Tiantan Hospital in Beijing, with a clinical focus on brain tumor surgery, glioma, meningioma, craniopharyngioma, central neurocytoma, and minimally invasive approaches guided by functional imaging and electrophysiological monitoring.
Professional Title & Qualifications:
Chief Physician,
Professor,
Doctoral Supervisor
Hospital & Department：
Beijing Tiantan Hospital – Department of Neurosurgery
(address: No. 119 South Fourth Ring West Road, Fengtai District, Beijing, 100070)
Dr. Song Lin (林松) - Neurosurgery Specialist
Personal Biography
Dr. Song Lin is a Chief Physician and Professor in the Department of Neurosurgery at Beijing Tiantan Hospital, Capital Medical University. With more than 30 years of experience in neurosurgical clinical practice, medical education and research, he focuses on the surgical management of brain tumors, including approaches that use minimally invasive techniques, functional imaging and electrophysiological monitoring to support neurological preservation. Dr. Lin completed his postgraduate medical education at Capital Medical University, earning both master’s and doctoral degrees, and manages an annual outpatient volume exceeding 4,000 visits and more than 500 surgeries annually.
Why Choose Dr. Song Lin?
High-volume neurosurgical practice: Dr. Lin has served as the primary surgeon for more than 10,000 neurosurgical procedures over a 30-year career, giving international patients a strong specialist profile to consider for complex brain tumor review and pre-travel planning.
Functional preservation focus: For tumors located near functional brain regions, Dr. Lin uses intraoperative functional MRI navigation and electrophysiological monitoring to support surgical planning that prioritizes neurological pathway protection.
Minimally invasive tumor-surgery techniques: His work includes transventricular and para-fascicular approaches for complex conditions such as deep-seated meningiomas, central neurocytomas and craniopharyngiomas, helping patients prepare clearer questions before considering treatment in China.
Pre-Travel Case Review & Specialist Liaison
International neurosurgical care requires careful medical-record preparation, imaging organization and clear pre-travel planning. Before arranging travel, patients can request MedBridgeNZ coordination for a remote specialist-review pathway with Dr. Song Lin where available, using client-authorized medical records, imaging files and clinical questions.
MedBridgeNZ helps organize records, coordinate translation where needed, transfer documentation with client authorization and support appointment-request communication with the relevant third-party specialist office or hospital.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Song Lin
Areas of Expertise
Glioma: Surgical management of gliomas, integrating functional MRI navigation and electrophysiological monitoring to target maximum resection and function preservation.
Meningioma: Resection of deep-seated meningiomas, including those in the posterior third ventricle, lateral ventricle, and sphenoid ridge, utilizing para-fascicular approaches.
Craniopharyngioma: Surgical intervention for complex craniopharyngiomas, incorporating techniques focused on the protection of pituitary and hypothalamic functions.
Central Neurocytoma: Application of minimally invasive channel approaches for the resection of large central neurocytomas.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
8,500 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
January 2016 – Present: Doctoral Supervisor, Beijing Tiantan Hospital.
November 2011 – Present: Professor, Beijing Tiantan Hospital.
November 2004 – Present: Chief Physician and Department Director, Beijing Tiantan Hospital.
November 1998 – November 2004: Associate Chief Physician, Beijing Tiantan Hospital.
Education & Training
Postgraduate medical education, Master's and Doctoral degrees, Capital Medical University.
Awards & Honors
Third Prize of the Beijing Science and Technology Progress Award.
2013: Academic Leader, Beijing Health System High-level Talent Training Plan.
2011: Beijing Science and Technology Progress Award, Third Prize (Research on new treatment technologies for malignant glioma).
2001: Beijing Science and Technology Progress Award, Second Prize (Research on the inhibitory effects of wild-type p53 gene on glioma).
2000: Beijing Health Bureau Social Science Award, First Prize (Experimental research on thymidine kinase gene therapy for malignant gliomas).
Academic & Professional Memberships
Senior Member, American Association of Neurological Surgeons (AANS).
Vice Chairman, Neuro-oncology Professional Committee, Beijing Anti-Cancer Association.
Member, Neuro-oncology Branch, Chinese Anti-Cancer Association.
Member, Neuro-oncology Branch, Chinese Neuroscience Society.
Standing Committee Member, Plastic and Craniofacial Biomaterials and Applications Professional Committee, Chinese Society for Biomaterials.
Principal Investigator (PI), Beijing Institute for Brain Disorders.
Research & Publications
Editor-in-Chief of the publication Primary Central Nervous System Lymphoma (2012).
Co-author of medical textbooks, including Neurosurgery (2021) and Wang Zhongcheng's Neurosurgery (2015).
Author of multiple peer-reviewed studies published in SCI-indexed journals focusing on glioma molecular features, prognosis stratification, and clinical treatments.
Selected Peer-Reviewed Publications
Below is a selection of Dr. Song Lin's highly cited clinical research, demonstrating ongoing leadership in the treatment and diagnostic evaluation of complex conditions:
Li M, et al. (2022). Combining hyperintense FLAIR rim and radiological features in identifying IDH mutant 1p/19q non-codeleted lower-grade glioma. European Radiology. Read on PubMed (PMID: 35079884)
Li M, et al. (2021). Combining MGMT promoter pyrosequencing and protein expression to optimize prognosis stratification in glioblastoma. Cancer Science. Read on PubMed (PMID: 34115910)
Li M, et al. (2020). Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications. Frontiers in Oncology. Read on PubMed (PMID: 33251147)
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
How can I request remote specialist-review coordination with Dr. Song Lin from outside China?
You can submit your current medical records, imaging files and key clinical questions to MedBridgeNZ for administrative preparation and translation coordination. Where available, MedBridgeNZ can support client-authorized document transfer and appointment-request communication with the relevant specialist office for a remote written specialist-review pathway before you consider travel to China. The medical review itself is performed by the appropriate licensed specialist or hospital.
Can Dr. Lin review whether minimally invasive neurosurgical approaches may be relevant to my case?
Suitability for a specific neurosurgical approach depends on pathology, tumor location, prior treatment history, imaging findings and overall health. MedBridgeNZ can help organize your records for specialist appointment triage or preliminary case-screening where available. Any comments on treatment options, surgical approach or next steps must come from the third-party specialist or hospital after reviewing your materials.
If an in-person pathway in China is recommended, how can MedBridgeNZ help?
If you choose to pursue care in China after third-party specialist review, MedBridgeNZ can assist with appointment request coordination, medical invitation or visa-document coordination support, translation coordination, travel planning and non-clinical bilingual administrative support. Appointment availability, admission steps, clinical decisions and hospital requirements remain under the relevant hospital or specialist office.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. For cases involving doctors such as Dr. Song Lin, we can help with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.